Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending higher, below historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-85.35M
↓ 95% below average
Average (9y)
$-43.88M
Historical baseline
Range
High:$88.33M
Low:$-137.21M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $-85.35M | +29.9% |
| 2024 | $-121.69M | +11.3% |
| 2023 | $-137.21M | -10.8% |
| 2022 | $-123.84M | -13.0% |
| 2021 | $-109.57M | -163.1% |
| 2020 | $-41.64M | -213.3% |
| 2019 | $36.74M | -58.4% |
| 2018 | $88.33M | +258.9% |
| 2017 | $24.61M | -20.2% |
| 2016 | $30.84M | - |